Company
Inspire
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
3
510(k), De Novo and PMA
Device trials
11
As lead sponsor, any status
Adverse event reports
1,007
Received Nov 1, 2025 to Nov 20, 2026
Recall records
6
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Inspire, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Inspire.
Latest FDA decisions
- Inspire Upper Airway Stimulation SystemPMA supplement
P130008-S090 · Decided Jun 8, 2023 · 234 days after receipt · Panel Track
Device type: Stimulator, hypoglossal nerve, implanted, apnea (MNQ) · Anesthesiology & Respiratory
- Inspire Upper Airway StimulationPMA supplement
P130008-S089 · Decided Mar 20, 2023 · 213 days after receipt · Panel Track
Device type: Stimulator, hypoglossal nerve, implanted, apnea (MNQ) · Anesthesiology & Respiratory
- Inspire Upper Airway StimulationPMA supplement
P130008-S039 · Decided Apr 14, 2020 · 447 days after receipt · Panel Track
Device type: Stimulator, hypoglossal nerve, implanted, apnea (MNQ) · Anesthesiology & Respiratory
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Effects of Hypoglossal Nerve Stimulation on Cognition and Language in Down Syndrome and Obstructive Sleep ApneaActive, not recruiting
NCT04801771 · 57 participants · Start Jun 24, 2021 · Primary completion Jul 1, 2026
Device: Inspire Upper Airway Stimulation (UAS) System · For: Down Syndrome; Obstructive Sleep Apnea
Sites: Atlanta, Georgia; Boston, Massachusetts; Cincinnati, Ohio · 8 sites in all
- Inspire Singapore StudyCompleted
NCT06540716 · 44 participants · Start Jul 25, 2024 · Primary completion Jul 17, 2025
Device: Inspire System · For: Obstructive Sleep Apnea; OSA; Sleep Apnea
Sites: Singapore, Singapore · 2 sites in all
- Inspire UAS High Apnea Hypopnea Index (AHI)/High Body Mass Index (BMI) Post-Approval StudyRecruiting
NCT07113288 · 70 participants (planned) · Start Jul 31, 2025 · Primary completion Jan 1, 2032
Device: Inspire® UAS System · For: Obstructive Sleep Apnea (OSA)
Sites: Colorado Springs, Colorado; Bradenton, Florida; Chicago, Illinois · 5 sites in all
8 more trials with a free account
Reports received
1,007
Received Nov 1, 2025 to Nov 20, 2026. Includes 1 of another or unstated type.
Malfunction reports
20
2.0% of reports
Injury reports
986
98% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 1 | 60 | 1 | 0 |
| Jan 24 | 4 | 55 | 0 | 0 |
| Feb 24 | 3 | 41 | 0 | 0 |
| Mar 24 | 0 | 48 | 0 | 0 |
| Apr 24 | 8 | 55 | 0 | 0 |
| May 24 | 0 | 68 | 0 | 0 |
| Jun 24 | 4 | 42 | 0 | 0 |
| Jul 24 | 2 | 59 | 0 | 1 |
| Aug 24 | 1 | 48 | 0 | 0 |
| Sep 24 | 1 | 52 | 0 | 0 |
| Oct 24 | 4 | 51 | 0 | 0 |
| Nov 24 | 4 | 61 | 1 | 0 |
| Dec 24 | 3 | 79 | 0 | 0 |
| Jan 25 | 4 | 52 | 0 | 0 |
| Feb 25 | 1 | 70 | 1 | 0 |
| Mar 25 | 1 | 67 | 0 | 0 |
| Apr 25 | 0 | 76 | 0 | 0 |
| May 25 | 2 | 94 | 0 | 0 |
| Jun 25 | 2 | 102 | 0 | 0 |
| Jul 25 | 2 | 66 | 0 | 0 |
| Aug 25 | 1 | 83 | 0 | 0 |
| Sep 25 | 1 | 79 | 0 | 0 |
| Oct 25 | 1 | 76 | 0 | 0 |
| Nov 25 | 3 | 97 | 0 | 0 |
| Dec 25 | 2 | 76 | 0 | 0 |
| Jan 26 | 4 | 100 | 0 | 0 |
| Feb 26 | 3 | 82 | 0 | 0 |
| Mar 26 | 1 | 86 | 0 | 0 |
| Apr 26 | 0 | 87 | 0 | 0 |
| May 26 | 2 | 66 | 0 | 0 |
| Jun 26 | 3 | 76 | 0 | 0 |
| Jul 26 | 0 | 65 | 0 | 0 |
| Aug 26 | 0 | 80 | 0 | 1 |
| Sep 26 | 1 | 90 | 0 | 0 |
| Oct 26 | 1 | 81 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2515-2026 · Started May 11, 2026 · Posted by FDA Jun 18, 2026
Reason given: Products are labeled with incorrect Use By Date, extending beyond the validated three-year shelf life from date of manufacturer. Material degradation of a product past its Use By Date may result in unplanned or premature revision surgery.
Cause as FDA categorized it: Process control · Device type: Stimulator, Hypoglossal Nerve, Implanted, Apnea (MNQ)
Z-2516-2026 · Started May 11, 2026 · Posted by FDA Jun 18, 2026
Reason given: Products are labeled with incorrect Use By Date, extending beyond the validated three-year shelf life from date of manufacturer. Material degradation of a product past its Use By Date may result in unplanned or premature revision surgery.
Cause as FDA categorized it: Process control · Device type: Stimulator, Hypoglossal Nerve, Implanted, Apnea (MNQ)
- Inspire Model 4340 Respiratory Sensing Lead, component of the Inspire Upper Airway Stimulation (UAS) system.Open, Classified
Z-0040-2025 · Started Jul 31, 2024 · Posted by FDA Oct 9, 2024
Reason given: Labeling error with a mismatch between the shelf box serial number label and the serial number of the lead provided in the box.
Cause as FDA categorized it: Process control · Device type: Stimulator, Hypoglossal Nerve, Implanted, Apnea (MNQ)
3 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.